Literature DB >> 25022811

ACG clinical guideline: management of benign anorectal disorders.

Arnold Wald1, Adil E Bharucha2, Bard C Cosman3, William E Whitehead4.   

Abstract

These guidelines summarize the definitions, diagnostic criteria, differential diagnoses, and treatments of a group of benign disorders of anorectal function and/or structure. Disorders of function include defecation disorders, fecal incontinence, and proctalgia syndromes, whereas disorders of structure include anal fissure and hemorrhoids. Each section reviews the definitions, epidemiology and/or pathophysiology, diagnostic assessment, and treatment recommendations of each entity. These recommendations reflect a comprehensive search of all relevant topics of pertinent English language articles in PubMed, Ovid Medline, and the National Library of Medicine from 1966 to 2013 using appropriate terms for each subject. Recommendations for anal fissure and hemorrhoids lean heavily on adaptation from the American Society of Colon and Rectal Surgeons Practice Parameters from the most recent published guidelines in 2010 and 2011 and supplemented with subsequent publications through 2013. We used systematic reviews and meta-analyses when available, and this was supplemented by review of published clinical trials.

Entities:  

Mesh:

Year:  2014        PMID: 25022811     DOI: 10.1038/ajg.2014.190

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  91 in total

1.  Resting anal pressure, not outlet obstruction or transit, predicts healthcare utilization in chronic constipation: a retrospective cohort analysis.

Authors:  K Staller; K Barshop; B Kuo; A N Ananthakrishnan
Journal:  Neurogastroenterol Motil       Date:  2015-07-14       Impact factor: 3.598

2.  Home Biofeedback for the Treatment of Dyssynergic Defecation: Does It Improve Quality of Life and Is It Cost-Effective?

Authors:  Satish S C Rao; Jorge T Go; Jessica Valestin; John Schneider
Journal:  Am J Gastroenterol       Date:  2019-06       Impact factor: 10.864

3.  Theoretical tools to analyze anorectal mechanophysiological data generated by the Fecobionics device.

Authors:  Donghua Liao; Abbey Sc Chen; Kar Man Lo; Jingbo Zhao; Kaori Futaba; Hans Gregersen
Journal:  J Biomech Eng       Date:  2019-06-26       Impact factor: 2.097

4.  Long-term outcomes of Botulinum toxin in the treatment of chronic anal fissure: 5 years of follow-up.

Authors:  Sandra Barbeiro; Catarina Atalaia-Martins; Pedro Marcos; Cláudia Gonçalves; Manuela Canhoto; Bruno Arroja; Filipe Silva; Isabel Cotrim; Liliana Eliseu; Antonieta Santos; Helena Vasconcelos
Journal:  United European Gastroenterol J       Date:  2016-07-08       Impact factor: 4.623

5.  Hemorrhoids and the recurrent attempts to destroy them.

Authors:  Carlo Ratto
Journal:  Tech Coloproctol       Date:  2016-12-20       Impact factor: 3.781

Review 6.  Will MRI of gastrointestinal function parallel the clinical success of cine cardiac MRI?

Authors:  Caroline Hoad; Christopher Clarke; Luca Marciani; Martin John Graves; Maura Corsetti
Journal:  Br J Radiol       Date:  2018-10-24       Impact factor: 3.039

Review 7.  Common Functional Gastroenterological Disorders Associated With Abdominal Pain.

Authors:  Adil E Bharucha; Subhankar Chakraborty; Christopher D Sletten
Journal:  Mayo Clin Proc       Date:  2016-08       Impact factor: 7.616

8.  Management of pelvic floor disorders: biofeedback and more.

Authors:  David Prichard; Adil E Bharucha
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

9.  Reproducibility of high-definition (3D) manometry and its agreement with high-resolution (2D) manometry in women with fecal incontinence.

Authors:  S Chakraborty; K J Feuerhak; A R Zinsmeister; A E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2016-10-02       Impact factor: 3.598

Review 10.  Endpoints for therapeutic interventions in faecal incontinence: small step or game changer.

Authors:  S S C Rao
Journal:  Neurogastroenterol Motil       Date:  2016-08       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.